Usefulness of circulating Chromogranin A (CgA) for the diagnosis of neuroendocrine tumors (NEN) is controversial. The aim of the present study was to assess the actual role of this marker as diagnostic tool.
Limitations of Chromogranin A in clinical practice / Marotta, V., Nuzzo, V., Ferrara, T., Zuccoli, A., Masone, M., Nocerino, L., Del Prete, M., Marciello, F., Ramundo, V., Lombardi, G., Vitale, M., Colao, A., Faggiano, A.. - In: BIOMARKERS. - ISSN 1354-750X. - 17:2(2012), pp. 186-191. [10.3109/1354750X.2012.654511]
Limitations of Chromogranin A in clinical practice
Ramundo, Valeria;Faggiano, Antongiulio
2012
Abstract
Usefulness of circulating Chromogranin A (CgA) for the diagnosis of neuroendocrine tumors (NEN) is controversial. The aim of the present study was to assess the actual role of this marker as diagnostic tool.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Marotta_Limitations-ChromograninA_2012.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
747.13 kB
Formato
Adobe PDF
|
747.13 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
